The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.
| Image |  |
|---|---|
| Description | scientific article published in March 2006 |
| Author/s |
author: Charlie Tomson Simon Ball Martin Landray |
| Publication date | March 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |